Navigation Links
HIV antibodies block infection by reservoir-derived virus in laboratory study
Date:8/26/2014

WHAT:

A laboratory study led by scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), lends further weight to the potential effectiveness of passive immunotherapy to suppress HIV in the absence of drug treatment. Passive immunotherapy for HIV is an experimental strategy that involves periodically administering broadly neutralizing HIV-specific antibodies (bNAbs) to control the virus. It would be advantageous to control HIV without antiretroviral drugs because of their cost, the potential for cumulative toxicities from lifelong therapy, and the difficulties some patients have adhering to drug regimens and tolerating certain drugs.

Although bNAbs have proven effective at blocking infection by various strains of HIV in the laboratory, their effect on HIV in humans, and particularly on the virus particles that hide in immune cells (called latent viral reservoirs), has been unknown.

In this study, NIH scientists obtained HIV from the latent reservoirs of 29 infected people in whom antiretroviral therapy fully inhibited viral replication. In the laboratory, the researchers found that several bNAbsparticularly PGT121, VRC01 and VRC03 effectively blocked HIV from entering the CD4+ T cells obtained from uninfected healthy donors. In addition, the scientists demonstrated in the laboratory that these antibodies could completely block HIV replication in CD4+ T cells obtained from infected individuals receiving antiretroviral therapy.

The researchers conclude that passive immunotherapy involving bNAbs individually or in combination may control HIV in the absence of antiretroviral therapy. A number of clinical trials are already underway or planned to test this hypothesis.


'/>"/>

Contact: Laura S. Leifman
laura.sivitz@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert  

Page: 1

Related medicine news :

1. No correlation between baby formulas and development of diabetes-associated autoantibodies
2. Antibodies from the desert as guides to diseased cells
3. NIH grantees sharpen understanding of antibodies that may cut risk of HIV infection
4. NIH scientists find mechanism that helps HIV evade antibodies, stabilize key proteins
5. Monoclonal Antibodies Market in Gastric and Esophageal Cancers to Reach USD 766 Mln by 2019, Says GBI Research in Its Report Available at MarketPublishers.com
6. Higher mortality in postmenopausal women with RA and anti-CCP antibodies
7. Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
8. Ben-Gurion U. and Sorrento Therapeutics sign agreement to develop anti-hepatitis C virus antibodies
9. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
10. Monoclonal Antibodies Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
11. Research reveals how antibodies neutralize mosquito-borne virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV antibodies block infection by reservoir-derived virus in laboratory study
(Date:12/6/2018)... ... 2018 , ... HMP, a leader in healthcare events and ... will take place May 9–10, 2019, and will be co-located with the Symposium ... , PACS is uniquely designed to provide nurses with the important tools they ...
(Date:12/6/2018)... ... 06, 2018 , ... Pulse8’s Senior Director of Quality Products, ... Blue Shield of Kansas City, will present on “Boosting Stars Scores by Better ... at the Fairmont Grand Del Mar in San Diego, California. , During ...
(Date:12/5/2018)... and DALLAS, Texas (PRWEB) , ... December 05, ... ... again proved its leading SkinPen Precision device is setting a new standard as ... record-setting Aesthetics Everything win. , Each year this award is presented at the ...
(Date:12/5/2018)... ... December 05, 2018 , ... A well-known name in ... content to the masses. Wellbeats , which has delivered on-demand, virtual fitness programming ... Wellbeats consumer app. Available now in the Apple App Store, the Wellbeats app ...
(Date:12/5/2018)... ... 05, 2018 , ... Advanced Clinical, a clinical research ... office location in Paris, France during the Partnerships in Clinical Trials Europe conference. ... and additional in-country personnel. , “The new office broadens our CRO and FSP ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... WHO: The Institute for Healthcare Improvement ... of four keynote addresses and five spotlight sessions taking place during the 30th annual ... and speakers) , WHEN: Beginning Tuesday, December 11 ( full schedule ) , ...
(Date:12/5/2018)... ... December 04, 2018 , ... Florida Hospital West ... and quality. Today, the prestigious Leapfrog Group, a national nonprofit health care ratings ... Hospital Heartland Medical Center Sebring, Florida Hospital Wesley Chapel and Florida Hospital Zephyrhills ...
(Date:12/5/2018)... ... 05, 2018 , ... Two women with a vision to make the blind ... , Jean Bennett, M.D., Ph.D., and Katherine A. High, M.D., whose work with the ... 4 at Sanford Health, headquartered in Sioux Falls, South Dakota. , “I want ...
Breaking Medicine Technology: